S C Inglis
Overview
Explore the profile of S C Inglis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
2071
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Franco-Trigo L, Hossain L, Durks D, Fam D, Inglis S, Benrimoj S, et al.
Res Social Adm Pharm
. 2016 Aug;
13(3):539-552.
PMID: 27485770
Background: Participatory approaches involving stakeholders across the health care system can help enhance the development, implementation and evaluation of health services. These approaches may be particularly useful in planning community...
2.
Inglis S, Lewsey J, Chandler D, Byrne D, Lowe G, Macintyre K
Br J Surg
. 2012 Feb;
99(5):680-7.
PMID: 22318673
Background: This study examined trends for all first hospital admissions for peripheral artery disease (PAD) in Scotland from 1991 to 2007 using the Scottish Morbidity Record. Methods: First admissions to...
3.
Zhang X, De Alwis M, Hart S, Fitzke F, Inglis S, Boursnell M, et al.
Hum Gene Ther
. 1999 Oct;
10(15):2527-37.
PMID: 10543617
Production of high-titer rAAV is essential for in vivo clinical application. One limiting factor may be the failure of existing systems to replicate the packaging genome in such a way...
4.
Disabled infectious single cycle (DISC) herpes simplex virus as a vector for immunotherapy of cancer
Boursnell M, Entwisle C, Ali S, Sivasubramaniam S, Reeder S, McLean C, et al.
Adv Exp Med Biol
. 1999 Feb;
451:379-84.
PMID: 10026900
No abstract available.
5.
Boursnell M, Entwisle C, Blakeley D, Roberts C, Duncan I, Chisholm S, et al.
J Infect Dis
. 1997 Jan;
175(1):16-25.
PMID: 8985191
A glycoprotein H (gH)-deleted herpes simplex virus type 2 (HSV-2) was evaluated as a vaccine for the prevention of HSV-induced disease. This virus, which we term a DISC (disabled infectious...
6.
Boursnell M, Rutherford E, Hickling J, Rollinson E, Munro A, Rolley N, et al.
Vaccine
. 1996 Nov;
14(16):1485-94.
PMID: 9014288
The presence and consistent expression of the genes encoding the human papillomavirus (HPV) E6 and E7 proteins in the great majority of cervical tumours presents the opportunity for an immunotherapeutic...
7.
McLean C, Ni Challanain D, Duncan I, Boursnell M, Jennings R, Inglis S
Vaccine
. 1996 Jul;
14(10):987-92.
PMID: 8873393
The vaccine potential of a genetically disabled Herpes Simplex Virus Type 1 virus (DISC HSV-1) was investigated in the guinea pig model of intravaginal (i.vag.) HSV-2 infection. Three mucosal vaccination...
8.
Borysiewicz L, Fiander A, Nimako M, Man S, Wilkinson G, Westmoreland D, et al.
Lancet
. 1996 Jun;
347(9014):1523-7.
PMID: 8684105
Background: Human papillomavirus (HPV) infection, especially with type 16 or 18, is associated with cervical cancer. Two HPV proteins, E6 and E7, are consistently expressed in tumour cells. The objectives...
9.
Blok V, Cianci C, Tibbles K, Inglis S, Krystal M, Digard P
J Gen Virol
. 1996 May;
77 ( Pt 5):1025-33.
PMID: 8609468
The influenza virus RNA polymerase consists of a heterotrimeric complex of the PB1, PB2 and PA proteins, with the PB2 subunit responsible for recognizing 5' cap structures on the host...
10.
Inglis S
Trends Biotechnol
. 1995 Apr;
13(4):135-42.
PMID: 7766109
The biological complexities of the human herpesviruses and the wide range of diseases that they cause present many difficulties for vaccine development. Until recently, progress towards this aim has been...